文献速递浆细胞疾病淋巴瘤

MASS-FIX在临床中检测和监测单克隆蛋白的应用价值

The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic.
PubMed 文献 · Am J Hematol · 2017-06-01

研究比较MASS-FIX与蛋白电泳、血清/尿免疫固定电泳及血清游离轻链在257例患者中识别单克隆蛋白的能力。血清/尿MASS-FIX在18例常规方法阴性患者中检出单克隆蛋白,其中10例为多发性骨髓瘤或AL淀粉样变性。MASS-FIX灵敏度与常规方法相当,有助于临床诊断。

要点

  • 血清/尿MASS-FIX在18例常规方法阴性患者中检出单克隆蛋白,其中10例为多发性骨髓瘤或AL淀粉样变性。
  • 6例血清免疫固定电泳和游离轻链比值阳性而血清MASS-FIX阴性,联合尿MASS-FIX后仅漏诊1例轻链型MGUS。
  • 近半数AL淀粉样变性患者具有非典型质谱图谱,可能成为诊断和发病机制的线索。

核心结论

  • MASS-FIX的灵敏度与蛋白电泳、免疫固定电泳及游离轻链方法相当,有助于临床诊断。

研究设计与样本

  • 研究比较MASS-FIX与蛋白电泳、血清/尿免疫固定电泳及定量血清游离轻链,检测257例患者的配对血清和尿样本。

主要发现

  • 血清/尿MASS-FIX在18例血清/尿蛋白电泳、免疫固定电泳及血清游离轻链均阴性的患者中检出单克隆蛋白,其中10例为多发性骨髓瘤或AL淀粉样变性。
  • 6例血清免疫固定电泳和游离轻链比值阳性而血清MASS-FIX阴性,联合血清和尿MASS-FIX后仅漏诊1例轻链型MGUS。
  • 近半数AL淀粉样变性患者具有非典型质谱图谱。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The detection and quantification of monoclonal-proteins (M-proteins) are necessary for the diagnosis and evaluation of response in plasma cell dyscrasias. Immunoglobulin enrichment-coupled with matrix-assisted laser desorption ionization time-of-flight mass-spectrometry (MASS-FIX) is a simple and inexpensive method to identify M-proteins, but its clinical generalizability has not yet been elucidated. We compared MASS-FIX to protein electrophoresis (PEL), serum/urine immunofixation-electrophoresis (IFE), and quantitative serum free-light chain (FLC) for the identification of M-proteins in different clinical diagnoses. Paired serum and urine samples from 257 patients were tested. There were six patients for whom s-IFE and FLC ratio were positive and serum MASS-FIX was negative, but when serum and urine MASS-FIX results were combined, only one patient with light chain-MGUS was missed. Serum/urine-MASS-FIX detected M-proteins in 18 patients with negative serum/urine-PEL/IFE and serum-FLC, 10 of whom had multiple myeloma or AL amyloidosis, who were mistakenly thought to have complete hematologic response by serum/urine-PEL/IFE and serum-FLC. Nearly half of the AL amyloidosis patients had atypical spectra, which may prove to be a clue to the diagnosis and pathogenesis of the disease. In conclusion, MASS-FIX has a comparable sensitivity with PEL/IFE/FLC methods and can help inform the clinical diagnosis.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Milani P, Murray DL, Barnidge DR, et al. The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic. Am J Hematol. 2017. PMID: 28439985. doi:10.1002/ajh.24772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。